Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 6 October 2027
- Last conf. stmt
- 22 September 2026
Rathlin Therapeutics Limited
- Incorporated
- 23 September 2022 (4 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Ian DukesGeert-Jan MulderJulen Oyarzabal
- Accounts type
- Small
- Region
- Greater London
- Address
- 6th FloorOne London WallLondonEC2Y 5EB
Officers 4 active
Officer details are public data from the Companies House register.
Dukes, Ian, Dr
Director · Appointed 1 September 2023
English
Born June 1958 (68)
Mulder, Geert-Jan
Director · Appointed 1 September 2023
Dutch
Born July 1966 (60)
Oyarzabal, Julen
Director · Appointed 1 September 2023
Spanish
Born October 1970 (56)
Director · Appointed 23 September 2022
British
Born October 1961 (65)
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
17 March 2025
1 September 2023
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 September 2026 | Accounts for a small company | 31 December 2025 | ||
| 7 August 2026 | Change of share class name or designation | |||
| 7 August 2026 | Particulars of variation of rights attached to shares | |||
| 8 October 2025 | Accounts for a small company | 31 December 2024 | 16 | |
| 2 October 2025 | Confirmation statement with updates | 22 September 2025 | 6 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →